RedHill Biopharma Announces FDA Clearance for Pivotal Phase 3 St
RDHL: RedHill Biopharma Ltd.
2020-07-31 07:00:10
RedHill Biopharma Announces FDA Clearance for Pivotal Phase 3 Study with RHB-204 for NTM Infections
2020-07-31 07:00:10
RedHill Biopharma Announces FDA Clearance for Pivotal Phase 3 Study with RHB-204 for NTM Infections
免责声明
这些信息和出版物并不意味着也不构成TradingView提供或认可的金融、投资、交易或其它类型的建议或背书。请在使用条款阅读更多信息。